HIV post-treatment controllers have distinct immunological and virological features
Proceedings of the National Academy of Sciences · 14.03.2023 · 120 (11)
DOI: 10.1073/pnas.2218960120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 06.03.2023. Verfasst von Behzad Etemad und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02139. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, HIV Infections. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, CCR NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
HIV post-treatment controllers (PTCs) are rare individuals who maintain low levels of viremia after stopping antiretroviral therapy (ART). Understanding the mechanisms of HIV post-treatment control will inform development of strategies aiming at achieving HIV functional cure. In this study, we evaluated 22 PTCs from 8 AIDS Clinical Trials Group (ACTG) analytical treatment interruption (ATI) studies who maintained viral loads ≤400 copies/mL for ≥24 wk. There were no significant differences in demographics or frequency of protective and susceptible human leukocyte antigen (HLA) alleles between PTCs and post-treatment noncontrollers (NCs, n = 37). Unlike NCs, PTCs demonstrated a stable HIV reservoir measured by cell-associated RNA (CA-RNA) and intact proviral DNA assay (IPDA) during analytical treatment interruption (ATI). Immunologically, PTCs demonstrated significantly lower CD4 + and CD8 + T cell activation, lower CD4 + T cell exhaustion, and more robust Gag-specific CD4 + T cell responses and natural killer (NK) cell responses. Sparse partial least squares discriminant analysis (sPLS-DA) identified a set of features enriched in PTCs, including a higher CD4 + T cell% and CD4 + /CD8 + ratio, more functional NK cells, and a lower CD4 + T cell exhaustion level. These results provide insights into the key viral reservoir features and immunological profiles for HIV PTCs and have implications for future studies evaluating interventions to achieve an HIV functional cure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02139.
- Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA 02139.
- School of Medicine, Case Western Reserve University, Cleveland, OH 44106.
- Harvard T. H. Chan School of Public Health, Boston, MA 02115.
- School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233.
- Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD 21702.
ORCID-Profile: Xiaoming Sun, Daniela Moisi, Yuko Yuki, Maureen P Martin, Mary Carrington, Elizabeth Connick, Ronald Mitsuyasu, Michael Saag, Joseph J Eron, David M Margolis, Michael M Lederman
Förderung
- NIAID NIH HHS
- CCR NIH HHS
- NCI NIH HHS
- HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
- Ruth L. Kirschstein National Research Service Award (NRSA)
- Frederick National Laboratory for Cancer Research
Zitieren
APA
Etemad, B., Sun, X., Li, Y., Melberg, M., Moisi, D., Gottlieb, R., Ahmed, H., Aga, E., Bosch, R. J., Acosta, E. P., Yuki, Y., Martin, M. P., Carrington, M., Gandhi, R. T., Jacobson, J. M., Volberding, P., Connick, E., Mitsuyasu, R., Frank, I., …, & Li, J. Z. (2023). HIV post-treatment controllers have distinct immunological and virological features. Proceedings of the National Academy of Sciences, 120(11). https://doi.org/10.1073/pnas.2218960120
Vancouver
Etemad B, Sun X, Li Y, Melberg M, Moisi D, Gottlieb R, et al. HIV post-treatment controllers have distinct immunological and virological features. Proceedings of the National Academy of Sciences. 2023;120(11). doi:10.1073/pnas.2218960120
BibTeX
@article{Etemad2023,
author = {Etemad, Behzad and Sun, Xiaoming and Li, Yijia and Melberg, Meghan and Moisi, Daniela and Gottlieb, Rachel and Ahmed, Hayat and Aga, Evgenia and Bosch, Ronald J and Acosta, Edward P and Yuki, Yuko and Martin, Maureen P and Carrington, Mary and Gandhi, Rajesh T and Jacobson, Jeffrey M and Volberding, Paul and Connick, Elizabeth and Mitsuyasu, Ronald and Frank, Ian and Saag, Michael and Eron, Joseph J and Skiest, Daniel and Margolis, David M and Havlir, Diane and Schooley, Robert T and Lederman, Michael M and Yu, Xu G and Li, Jonathan Z},
title = {HIV post-treatment controllers have distinct immunological and virological features},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
volume = {120},
number = {11},
doi = {10.1073/pnas.2218960120}
}
EUVIMED